|
Home : Unsafe Drugs : Avandia : News Articles : Actos on FDA Watch List for Potential New Concerns Actos on FDA Watch List for Potential New Concerns
Washington, DC: It may have become the heir apparent to Avandia, but overshadowed by a steady stream of negative publicity surrounding the Type 2 diabetes drug manufactured by GlaxoSmithKline are concerns with regard to Actos side effects . To that end, the US Food ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




